References
- Warburg O, Wind F, Negelein E. The metabolism of tumors in the body. J Gen Physiol 1927; 8:519-30; PMID:19872213; http://dx.doi.org/10.1085/jgp.8.6.519
- Farnie G, Sotgia F, Lisanti MP. High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant. Oncotarget 2015; PMID:26421710; 6:30472-86; http://dx.doi.org/10.18632/oncotarget.5401
- Cipolleschi MG, Marzi I, Santini R, Fredducci D, Vinci MC, D'Amico M, Rovida E, Stivarou T, Torre E, Dello Sbarba P, et al. Hypoxia-resistant profile implies vulnerability of cancer stem cells to physiological agents, which suggests new therapeutic targets. Cell Cycle 2014; 13:268-78; PMID:24200964; http://dx.doi.org/10.4161/cc.27031.
- Altman BJ, Stine ZE, Dang CV. From Krebs to clinic: glutamine metabolism to cancer therapy. Nat Rev Cancer 2016; 16:619-34; PMID:27492215; http://dx.doi.org/10.1038/nrc.2016.71
- Yang M, Vousden KH. Serine and one-carbon metabolism in cancer. Nat Rev Cancer 2016; 16:650-62; PMID:27634448 http://dx.doi.org/10.1038/nrc.2016.81
- Gameiro PA, Laviolette LA, Kelleher JK, Iliopoulos O, Stephanopoulos G. Cofactor balance by nicotinamide nucleotide transhydrogenase (NNT) coordinates reductive carboxylation and glucose catabolism in the tricarboxylic acid (TCA) cycle. J Biol Chem 2013; 288:12967-77; PMID:23504317; http://dx.doi.org/10.1074/jbc.M112.396796.
- Cipolleschi MG, Marzi I, Rovida E, Olivotto M, Dello Sbarba P. Low-dose methotrexate enhances cycling of highly anaplastic cancer cells. Cell Cycle 2017; PMID:27841718; http://dx.doi.org/10.1080/15384101.2016.1252883